David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
Sintonize para discussões perspicazes com líderes da biotecnologia sobre desenvolvimento e fabricação de biofármacos. Aprenda estratégias para otimizar processos e acelerar terapias inovadoras.
202: Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days with José Bila - Part 2
E202 • 24 mins • Oct 30, 2025
Charts
- 104NEW
- 184NEW
- 181NEW
- 143Decreased by 7
- 187Decreased by 3
Episódios recentes

Oct 30, 2025
202: Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days with José Bila - Part 2
E202 • 24 mins

Oct 28, 2025
201: Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days with José Bila - Part 1
E201 • 25 mins

Oct 23, 2025
200: Mastering Quality by Design: From Product Failures to Commercial Success in Biologics CMC Development - Part 2
E200 • 21 mins

Oct 21, 2025
199: Mastering Quality by Design: From Product Failures to Commercial Success in Biologics CMC Development - Part 1
E199 • 21 mins

Oct 16, 2025
198: Mastering ADC Development: CDMO Strategies for Analytics and Scale-Up with Amanda Hoertz - Part 2
E198 • 22 mins

Idioma
Inglês
País
Estados Unidos
Feed Host
Website
Feed
Solicitar uma atualização
As atualizações podem levar alguns minutos.